MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection
Identifying new genes from various cancers which increase risk of disease, and creating risk profiles for the general population
MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection
ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies
Psychological issues in familial cancer
Best practice in HRRm testing in patients with metastatic prostate cancer
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Community-based breast cancer control programme in the Philipines
Initiatives for cancer control in Indonesia
OncoAlert round up July 28th to August 3rd, 2023
iCCaRE Consortium for Black Men: Second Discussion